This collaboration marks a significant stride for Imexpharm, empowering the company to delve deeper into the production of specialised medications at affordable prices, Imexpharm said in a statement.
In late April the finance ministry examined the country''s five largest
formula milk producers and decided to cap the prices of the 25 most
popular products in an attempt to protect consumers.
